ArticleCancer medicine2023

The impact of peroxisome proliferator-activated receptor-γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapy.

Cho-Han Chiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.